ID: ALA5280571

Max Phase: Preclinical

Molecular Formula: C41H65N5O18

Molecular Weight: 915.99

Associated Items:

Representations

Canonical SMILES:  CCCCCCCCCC[C@H](CC(=O)O[C@H]1CN(C)[C@@H](C(O[C@@H]2O[C@H](CN)[C@@H](O)[C@H]2O)[C@H]2O[C@@H](n3ccc(=O)[nH]c3=O)[C@H](O)[C@@H]2O)C(=O)N(C)[C@@H]1C(=O)O)OC(=O)C[C@H](C)CC(=O)O

Standard InChI:  InChI=1S/C41H65N5O18/c1-5-6-7-8-9-10-11-12-13-22(60-27(50)17-21(2)16-26(48)49)18-28(51)61-24-20-44(3)30(37(56)45(4)29(24)39(57)58)35(64-40-34(55)31(52)23(19-42)62-40)36-32(53)33(54)38(63-36)46-15-14-25(47)43-41(46)59/h14-15,21-24,29-36,38,40,52-55H,5-13,16-20,42H2,1-4H3,(H,48,49)(H,57,58)(H,43,47,59)/t21-,22-,23-,24+,29+,30+,31-,32+,33-,34-,35?,36+,38-,40+/m1/s1

Standard InChI Key:  VVLFISHNJLAURF-TVZWZLRASA-N

Associated Targets(non-human)

Mycobacterium avium 4587 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 915.99Molecular Weight (Monoisotopic): 915.4325AlogP: -1.58#Rotatable Bonds: 24
Polar Surface Area: 340.24Molecular Species: ZWITTERIONHBA: 19HBD: 8
#RO5 Violations: 3HBA (Lipinski): 23HBD (Lipinski): 9#RO5 Violations (Lipinski): 3
CX Acidic pKa: 3.06CX Basic pKa: 8.75CX LogP: -4.78CX LogD: -5.46
Aromatic Rings: 1Heavy Atoms: 64QED Weighted: 0.04Np Likeness Score: 1.27

References

1. Serpi M, Ferrari V, Pertusati F..  (2016)  Nucleoside Derived Antibiotics to Fight Microbial Drug Resistance: New Utilities for an Established Class of Drugs?,  59  (23): [PMID:27607900] [10.1021/acs.jmedchem.6b00325]

Source